Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
India's Equity Market Outperforms Asia-Pacific in October Amid Sector Rotation

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

India's Equity Market Outperforms Asia-Pacific in October Amid Sector Rotation

Analysed 2 Nov 2026·3 sources analysed·India·Business
India's Equity Market Outperforms Asia-Pacific in October Amid Sector RotationPreviousNext

Indian equities were among the top global performers in October 2026, outperforming the broader Asia-Pacific region excluding Japan by 7 percentage points, according to Goldman Sachs Research. This improvement followed a market rotation away from AI-sensitive North Asian markets and AI-linked domestic companies toward IT services. The NIFTY index rebounded 3% after a 10% decline in the third quarter, with mid-cap, small-cap, and pharmaceutical sectors also showing gains during the month.

Sentiment
70%
TBN's observations

First-hand measurement across 3 sources

We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (70/100). Lens Score 40/100.

Outlets measured: news18, moneycontrol, thetribune. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 3 sources · Published under editorial oversight by The Balanced News
Analysed 2 Nov 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Positive (70/100)

Sentiment was consistent across outlets (70–70/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

thetribune broke this story on 2 Nov, 04:43 am. Other outlets followed.

2 Nov, 04:43 am3 sources · 2 h2 Nov, 06:17 am
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
India and EU Discuss Implementation of Free Trade Agreement and Trade Cooperation
Next →
Real-Time Stock Updates and Analysis for Leading Indian Companies on November 2, 2026
  1. 1
    thetribune2 Nov, 04:43 am
    India outperforms global markets in October as investors rotate away from AI stocks: Goldman Sachs
  2. 2
    moneycontrol2 Nov, 05:10 am
    India goes from market laggard to global outperformer in October; Goldman Sachs explains why- Moneycontrol.com
  3. 3
    news182 Nov, 06:17 am
    Indian Stocks Outperform Global Markets In October As Investors Rotate Away From AI Stocks: Goldman Sachs

Who's involved

Institutions and figures named across source coverage.

Corporate
Goldman Sachs ResearchMSCI India

Story context

Category
Business
Location
India
Sources analysed
3
Last analysed
2 Nov 2026
Key entities
Goldman SachsAsiaIndiaStockInformation technologyArtificial intelligenceInstitutional investorMarket capitalizationAsia-PacificMSCIPharmaceutical industryValuation (finance)